Cream showdown: which hemorrhoid ointment works faster?
NCT ID NCT01881282
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested two creams for painful hemorrhoids: carraghenates cream and Mayinglong musk hemorrhoid ointment. 123 participants used one of the creams twice daily for 6 days. Researchers measured how quickly pain eased and how well symptoms like bleeding and swelling improved.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- carraghenates cream
- What this could lead to
- If it works, this could offer a new option for easing hemorrhoid pain and discomfort.
- What could go wrong
- This is a small, short-term Phase 4 trial comparing two existing treatments, so it may not lead to a major breakthrough. Results may not apply to everyone with hemorrhoids.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
123 people
The number who actually took part.
- Started
-
Dec 2006
- Finished
-
Feb 2008
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
16 to 75 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants who agree to participate in the current study * Participants having painful hemorrhoids (swollen veins in the lower part of the rectum or anus \[external hemorrhoid, mixed hemorrhoid, etc.\]) * Participants who did not use other topical drugs to treat their hemorrhoids a day before the inclusion * Participants who do not use drugs other than the study drug and the control drug to treat their hemorrhoids during the study period Exclusion Criteria: * Participants having other anorectal diseases , such as anal fistula , anal cleft , perianal abscess , and anorectal occupied lesions etc * Participants having hypersensitive predisposition or hypersensitive to any of components of the study drugs * Female participants under pregnancy or during breastfeeding period * Participants who fail to accept the scheduled visits or are lost to the visits * Participants complicated by serious cardio cerebro vascular diseases, hepatic and renal diseases, diseases of hemopoietic system or mental disorders
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hemorrhoids are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beijing Hospital
Beijing, 100730, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Suture-Free hemorrhoid operation cut recovery pain?
- Two needle paths, one goal: blocking hemorrhoid surgery pain
- Can a Long-Acting anesthetic ease Post-Surgery pain better than the standard?
- New Chinese-Language questionnaires aim to better measure hemorrhoid suffering
- Could a tiny camera make hemorrhoid surgery less painful?
- Could a common blood pressure drug be the key to pain-free hemorrhoid recovery?